Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “ADRENAL CORTEX”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,351 records · Page 75Linked to original sources

[Effect of chlorpromazine on K+-dependent regulation of aldosterone biosynthesis in guinea pig adrenal cortex].

The effects of chlorpromazine, a calmodulin inhibitor, on K(+)-dependent regulation of aldosterone biosynthesis were studied in sections and dispersed adrenocortical cells of guinea pigs. K ions in concentrations 5-11 mM significantly (p < 0.01) stimulated aldosterone and protein biosynthesis and protein phosphorylation in sections and cells of the guinea pig adrenal cortex. Using the radioautography of P-labeled polypeptides separated in polyacrylamide gel, the authors have demonstrated K+ enhancement of phosphate incorporation in the proteins with molecular masses of 40 and 75 kD in the cytosols and of 75 kD proteins in the mitochondria. Chlorpromazine in concentration 50 microM reduced K(+)-stimulated steroidogenesis and protein phosphorylation, simultaneously increasing labeled phosphate incorporation in the proteins in low K+ concentrations, not stimulating steroidogenesis. K(+)-stimulated protein biosynthesis was virtually unchanged in the presence of chlorpromazine. Increased K+ concentration in the medium resulted in reduction of cGMP concentration in adrenal cortex sections. The nucleotide level grew in the presence of chlorpromazine in elevated concentrations of K+ and reduced if the ion concentrations were low (1-3 mM). The mechanisms of chlorpromazine effect on K(+)-dependent steroidogenesis changes, protein phosphorylation and cGMP levels in the adrenocortical tissue are discussed, as is the role of calmodulin in K(+)-dependent regulation of aldosterone biosynthesis.

Adrenal Cortex↗

Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer's disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomas.

Selective Alzheimer's disease indicator-1 (seladin-1) is a novel gene with antiapoptotic activity that is down-regulated in vulnerable brain regions in Alzheimer's disease. This gene encodes 3-beta-hydroxysterol Delta-24-reductase (DHCR24), which converts desmosterol into cholesterol. In the adrenal cortex, increased expression of seladin-1/DHCR24, which appears to be modulated by ACTH, has been recently reported in cortisol-secreting adenomas, compared with the adjacent atrophic tissue. In our study, we measured the expression level of seladin-1/DHCR24 in cortisol- (n = 18) and aldosterone-secreting (n = 16) adrenocortical adenomas, in carcinomas (n = 17), and in normal adrenal glands (n = 8) by quantitative real-time RT-PCR. The amount of seladin-1/DHCR24 mRNA was significantly reduced in carcinomas (total RNA, 2.5 +/- 0.8 pg/ micro g) compared with the other groups (P < 0.01). Western blot analysis confirmed the mRNA results. Similarly, in adrenal malignancies, significantly reduced levels of expression of the ACTH receptor gene were found. In the adrenal cancer cell line H295R and in primary cultures from adrenocortical cells, ACTH (1 nM) and forskolin (10 micro M) effectively increased seladin-1/DHCR24 expression, confirming that seladin-1/DHCR24 is modulated by the ACTH/cAMP-driven pathway. In summary, this is the first demonstration that seladin-1/DHCR24 expression is reduced in adrenal cancer, suggesting that it might be viewed as a new potential marker of adrenal malignancies.

Adolescent↗

[Irritation of the hypothalamic structures and the function of the adenohypophysis and adrenal cortex in aneurysmal ruptures of the cerebral vessels].

Concurrent clinico-electroencephalographic and endocrinologic examination of the function of the hypothalamo-hypophyseal complex in patients in the acute period of rupture of aneurysms of the cerebral vessels showed that increase of the degree of irritation of the hypothalamic structures and the severity of the patient's condition is attended by activation of the function of the adenohypophysis and glucocorticoid function of the adrenal cortex. In loss of hypothalamic functional activity in patients whose condition is severe or very severe, the adrenocorticotropic function of the adenohypophysis is inhibited while the function of the adrenal cortex is sharply activated. No significant differences in the somatotropic function of the adenohypophysis in changes of the degree of hypothalamic structures irritation were revealed.

Acute Disease↗